share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  09/17 06:05

Moomoo AI 已提取核心信息

Conduit Pharmaceuticals, known in the stock market as CDT.US, has achieved a significant milestone with the United States Securities and Exchange Commission (SEC). On September 10, 2024, at 5:00 P.M., the SEC granted effectiveness to the company's Form F-1 filing. This development is a critical step for Conduit Pharmaceuticals, which operates under the legal name Genius Group Ltd, as indicated by its CIK number 0001847806. The effectiveness of the Form F-1, associated with file number 333-279795, marks a pivotal moment for the company's future financial activities.
Conduit Pharmaceuticals, known in the stock market as CDT.US, has achieved a significant milestone with the United States Securities and Exchange Commission (SEC). On September 10, 2024, at 5:00 P.M., the SEC granted effectiveness to the company's Form F-1 filing. This development is a critical step for Conduit Pharmaceuticals, which operates under the legal name Genius Group Ltd, as indicated by its CIK number 0001847806. The effectiveness of the Form F-1, associated with file number 333-279795, marks a pivotal moment for the company's future financial activities.
Conduit Pharmaceuticals,股票代号为CDt.US,在美国证券交易委员会(SEC)取得了重要的里程碑。于2024年9月10日下午5点,SEC批准了该公司的F-1表格申报生效。这一进展对于Conduit Pharmaceuticals来说是一个重要的步骤,该公司以Genius Group Ltd的法律名称运营,其CIk号码为0001847806。F-1表格的生效,与文件号333-279795相关,标志着该公司未来财务活动的关键时刻。
Conduit Pharmaceuticals,股票代号为CDt.US,在美国证券交易委员会(SEC)取得了重要的里程碑。于2024年9月10日下午5点,SEC批准了该公司的F-1表格申报生效。这一进展对于Conduit Pharmaceuticals来说是一个重要的步骤,该公司以Genius Group Ltd的法律名称运营,其CIk号码为0001847806。F-1表格的生效,与文件号333-279795相关,标志着该公司未来财务活动的关键时刻。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息